Small Molecule
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
70
NCT06578624
Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
Phase: Phase 1/2
Role: Lead Sponsor
Start: Mar 10, 2025
Completion: Dec 31, 2028
Loading map...